Cardiac pacemaking is governed by specialized cardiomyocytes located in the sinoatrial node (SAN). SAN cells (SANCs) integrate voltage-gated currents from channels on the membrane surface (membrane clock) with rhythmic Ca 2+ release from internal Ca 2+ stores (Ca 2+ clock) to adjust heart rate to meet hemodynamic demand. Here, we report that stromal interaction molecule 1 (STIM1) and Orai1 channels, key components of store-operated Ca 2+ entry, are selectively expressed in SANCs. Cardiac-specific deletion of STIM1 in mice resulted in depletion of sarcoplasmic reticulum (SR) Ca 2+ stores of SANCs and led to SAN dysfunction, as was evident by a reduction in heart rate, sinus arrest, and an exaggerated autonomic response to cholinergic signaling. Moreover, STIM1 influenced SAN function by regulating ionic fluxes in SANCs, including activation of a store-operated Ca 2+ current, a reduction in L-type Ca 2+ current, and enhancing the activities of Na + /Ca 2+ exchanger. In conclusion, these studies reveal that STIM1 is a multifunctional regulator of Ca 2+ dynamics in SANCs that links SR Ca 2+ store content with electrical events occurring in the plasma membrane, thereby contributing to automaticity of the SAN.
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STIM1 | pacemaker | SAN | channels | calcium S inus rhythm of the heart is set by specialized cardiomyocytes located in the sinoatrial node (SAN). These cardiomyocytes (SANCs) lack a resting membrane potential but generate a sinus impulse after spontaneous diastolic depolarization triggers an action potential (AP). Automaticity is achieved in the SANCs by the simultaneous activation of diastolic currents during membrane depolarization and the spontaneous release of Ca 2+ from internal stores (1) (2) (3) . Several recent studies show that maintenance of sarcoplasmic reticulum (SR) Ca 2+ stores is critically important for SAN automaticity, as is evident from genetic studies involving patients and mice that have leaky SR Ca 2+ stores (4) . Mutations in the ryanodine receptor (RYR2) or calsequestrin genes that result in spontaneous Ca 2+ release cause catecholamiergic polymorphic ventricular tachycardia (CPVT) (5, 6) . In addition to ventricular arrhythmias, these patients also develop sinus node dysfunction and bradycardia, which frequently requires permanent pacemaker insertion. Computational studies further reinforce the idea that SAN dysfunction results from leaky RYR2-containing Ca 2+ stores (5) . These studies emphasize the importance of Ca 2+ signaling in the automaticity of SANCs. Given the emerging role of store-operated Ca 2+ entry (SOCE) in excitable cells, we asked here whether stromal interaction molecule 1 (STIM1) plays a major role in regulating the Ca 2+ signaling and automaticity of SANCs.
SANs are structurally and functionally heterogeneous, exhibiting differences in shape and size that correspond to differences in electrophysiological features (7) . It is believed that this heterogeneity is required to establish regional zones within the SAN for impulse generation by pacemakers. Under resting conditions, clusters of SANCs serve as the dominant pacemaker by firing APs at rates faster than subsidiary pacemakers located in adjacent aspects of the SAN and atria. However, under different chronotropic conditions, as occurs with autonomic stimulation, the dominant pacemaking sites can shift to different regions within the SAN, where subsidiary pacemakers can slow or speed up the heart rate (HR) (8) . Dominant pacemakers are established by differences in ion channel distribution that create regional differences in electrophysiological properties such as the maximal diastolic potential (MDP) and the rate of diastolic depolarization. In addition, local intracellular factors also contribute to pacemaking by integrating currents generated at the plasma membrane with the rhythmic release of Ca 2+ from the SR. (15) . Surprisingly, very little STIM1 expression was detected in atrial or ventricular chambers. However, we did detect STIM1 in the SAN and coronary arteries of adult mouse heart ( Fig. 1 A-C) . STIM1-LacZ staining in whole mount hearts revealed STIM1 localization at the junctional region of the superior vena cava and the right atrial appendage, where the SAN is located (Fig. 1  B and C) . Serial sections of the heart from STIM1 +/LacZ mice demonstrated that the bulk of STIM1-LacZ staining extended from the edge of the crista terminalis to the interatrial septum, in a pattern consistent with the SAN area of the mouse heart ( Fig.  1D and Fig. S1 A and B) . This was further confirmed by detecting HCN4, a marker of the SAN, in the same region in which STIM1 was expressed (Fig. S1 C-F) . Given that STIM1 activates Orai1 channels, we used Orai1 specific antibodies to show that Orai1 is also expressed in the SAN, in a pattern similar to HCN4 (Fig. 1  E-G) . Because STIM1 was enriched in the SAN, we asked whether mice lacking STIM1 exhibited a phenotype attributable to changes in cardiac pacemaking. Indeed, we found that 6-wkold unanesthetized gene-trapped STIM1
−/− mice exhibited slower HRs than their WT littermates, as measured by electrocardiography [WT HR 688 ± 14 beats per minute (bpm) versus KO HR 621 ± 21 bpm; P < 0.05, n = 4 mice each genotype].
STIM1 Regulates a Store-Operated Ca 2+ Current in SANCs. Because constitutive deletion of STIM1 in mice leads to a severe skeletal muscle phenotype and early lethality (15), we used site specific recombination Cre/lox technology to delete STIM1 specifically in the heart. Cardiac-specific STIM1 −/− mice (cSTIM1
) were generated by crossing mice carrying the α-MHC-Cre transgene with a mouse line in which exon 2 of the Stim1 gene was flanked by lox P sites (16) . The cSTIM1 −/− mice appeared to develop normally and exhibited no obvious differences from control STIM1 fl/fl mice. The cSTIM1 −/− SAN lacked STIM1, as shown by immunostaining ( Fig. S1 C-F) . Moreover, STIM1 and Cre immunoblotting from heart lysates revealed a threefold reduction in STIM1 expression, indicating that STIM1 expression in non-Cre-expressing cells remained intact ( Fig. S1 G and H). We did not detect a difference in the expression of HCN4 or Orai1 in the cSTIM1 −/− SAN (Fig. S1G ). To determine whether STIM1 in SANCs activates a storeoperated Ca 2+ current (I soc ) and SOCE, we isolated SANCs from the hearts of STIM1 fl/fl and cSTIM1 −/− mice and used the wholecell patch clamp recording technique and protocols previously established for measuring I soc in nonexcitable cells (Fig. 2 A-C) . SANCs were held at a membrane potential of 0 mV and subjected to a standard ramp protocol from +100 mV to −100 mV. Inclusion of BAPTA (10 mM) (Fig. 3A , Right) indicated that Orai1 colocalized with HCN4 channels, suggesting that Orai1 was expressed in the plasma membrane of SANCs. STIM1 was localized in a transverse pattern typical of the Z line and also in a linear pattern underneath the sarcolemma (Fig. 3B ). This staining pattern strongly resembles that described for RYR2 in SANCs, which defines the SR compartment (17, 18) . Profile analysis validated that, in resting SANCs, STIM1 was present both in the subsarcolemmal compartment and in the Z-line compartment (Fig. 3B, Right) . Interestingly, SR Ca 2+ store depletion using the SR/ER Ca 2+ ATPase (SERCA) inhibitor cyclopiazonic acid (CPA, 30 μM) did not alter this distribution of STIM1 in SANCs (n = 9, Fig. 3 C and D) . Based on these observations, we conclude that STIM1 is positioned in the SR membrane at the Z-line and also in the subsarcolemmal SR, where it can interact with Orai1 channels to rapidly activate SOCE. These findings further suggest that STIM1 movement is limited in SANCs. Expression of STIM1 underneath the plasma membrane is likely to provide ready access to Orai1 channels to activate Ca 2+ entry. To broaden our understanding of the limited movement of STIM1 within the SR, we examined STIM1 in other excitable cells. We chose neonatal primary cardiomyocytes (NCMs) because they beat spontaneously and exhibit many of the electrophysiological features typical of SANCs (19) . NCMs were isolated from newborn STIM1
fl/fl and cSTIM1 −/− mouse hearts. Like cSTIM1
SANCs, NCMs from cSTIM1 −/− hearts also showed no SOCE (Fig. S2A ). We reintroduced STIM1 into the cSTIM1 −/− NCMs by infecting them with an adenovirus that carries rat STIM1-cherry red and found that this restored both SOCE and SR Ca 2+ refilling in cSTIM1 −/− NCMs (Fig. S2B) . Again, the pattern of STIM1-cherry red fluorescence in the NCMs exhibited minimal change on a beat-to-beat basis (Movie S1) or following CPAmediated Ca 2+ store depletion (Fig. S2C ). Based on these findings, we conclude that Ca 2+ store depletion in NCMs does not significantly alter STIM1 positioning in the SR. These findings support the notion that STIM1 movement is limited in striated muscle where dense sarcomeric material may restrict STIM1 diffusion in the SR. fl/fl SANCs, we observed a persistent I NCX1 following SR store depletion (Fig. 5D ). We hypothesized that this persistent NCX1 current was triggered by STIM1-dependent Ca 2+ entry through Orai1 channels. Supporting our hypothesis, the persistent NCX1 current was absent in cSTIM1 −/− SANCs (Fig.  5D ). We confirmed that loss of STIM1 in SANCs is responsible for depleting SR Ca 2+ stores, because reintroduction of STIM1 into the cSTIM1 −/− NCMs restored the ability to replenish the SR Ca 2+ stores (Fig. S2B ). These studies indicate that there is an intimate relationship between STIM1, I NCX1 , and I soc . We next assessed the steady-state I NCX1 density and found that I NCX1 was increased in cSTIM1 −/− SANCs ( Fig. 5 E and F) . We also found that there was a change in the reversal potential for the I NCX1 in cSTIM1 −/− SANCs. Recent studies demonstrate that STIM1 regulates voltagegated Ca 2+ currents via a direct physical interaction with Cav1.2 (20, 21) . In contrast to those works where silencing STIM1 led to greater L-type Ca 2+ currents (I Ca-L ), we found that the current density of I Ca-L was reduced in cSTIM1 −/− SANCs compared represented as mean ± SEM; ***P < 0.001, **P < 0.01; Student's t test for unpaired variances.
Loss of STIM1 in SANCs Markedly
with STIM1 fl/fl SANCs (Fig. S3A) . Interestingly, viral replacement of rat STIM1 in cSTIM1 −/− SANCs was able to rescue I Ca-L (Fig. S4) . Therefore, the reduction in I Ca-L may be due to the depletion of SR Ca 2+ stores in SANCs from cSTIM1 −/− mice, as has been described for SANCs harboring mutations in mouse RyR2 that cause CPVT (5, 22, 23 −/− mice (n = 22); P < 0.01) (Fig. 6A ). To investigate potential causes for the reduced HRs, we performed detailed invasive electrophysiological testing with ECG analysis in anesthetized mice (Table 1) . Here, we also observed a relatively slower HR in cSTIM1 −/− mice but no differences in conduction intervals between groups, thereby excluding defects in atrioventricular (AV) conduction. These data imply that the relative bradycardia in the cSTIM1 −/− mice derives from a SAN defect rather than a conduction system defect (Fig. 6B) .
To investigate the mechanistic basis for the SAN defect in the cSTIM1 −/− mice, we performed optical mapping of Ca 2+ transients in isolated SAN preparations from STIM1 fl/fl and cSTIM1
mice during spontaneous sinus rhythm. For STIM1 fl/fl SAN preparations (5/5 mice), spontaneous firing emerged from the edge of the crista terminalis near the superior vena cava (SVC) and propagated in a pattern typically described for the SAN (Fig.  6C , Top and Movie S2). In contrast, two distinct activation patterns with varied cycle lengths were noted for the cSTIM1 −/− SAN, indicating a shift in the primary pacemaking site. Specifically, at short cycle lengths, origination of the pacemaker occurred near the junction of the SVC and the crista terminalis. The impulses conducted rapidly, with no difference in conduction time between cSTIM1 −/− and STIM1 fl/fl SAN (Fig. 6C , Middle and Movie S3). However, at longer cycle lengths, the impulse initiation site shifted toward the atrial septum, resulting in the propagation of the impulse in the opposite direction (Fig.  6C , Bottom and Movie S4). Spontaneous pacemaker shifting was apparent in four of five cSTIM1 −/− SAN preparations, indicating that impulse generation is unstable in cSTIM1 −/− mice. Therefore, SANCs lacking STIM1 might be unable to efficiently refill stores, resulting in Ca 2+ clock dysfunction and unstable impulse generation.
Cholinergic Sensitivity and STIM1-SOCE in Mouse SAN. Parasympathetic tone is regulated by cholinergic signaling, which affects pacemaker function, enhances pacemaker shifting, slows the HR by altering the hyperpolarization-activated cation current (I f ) and the muscarinic receptor activated K + current (I K,Ach ), and reduces Ca 2+ transients (24) (25) (26) . We next examined whether deletion of STIM1 altered the sensitivity of the SAN in response to cholinergic stimulation. A single dose of the cholinergic agonist, carbachol (CCh, 100 μg/kg) significantly slowed the HR and induced sinus arrest in hearts of cSTIM1 −/− mice, whereas this same CCh dose only minimally slowed the HR in STIM1 fl/fl mice ( Fig. 7A and Table  1 ). Increased cholinergic sensitivity was also evident during invasive electrophysiological testing of cSTIM1 −/− mice ( Table 2) . When STIM1 fl/fl and cSTIM1 −/− mice were subjected to rapid atrial pacing for 30 s at a 100-ms cycle length, the time interval required for the SAN to recover after termination of rapid atrial pacing (corrected sinus node recovery time, cSNRT) was not different between cSTIM1 −/− mice and STIM1 fl/fl mice at baseline. After treatment with CCh, however, the cSNRT was significantly prolonged in cSTIM1 −/− mice compared with STIM1 fl/fl mice ( Fig. 7B and Table  2 ). In contrast to the exaggerated cholinergic response, there was no difference in HR between cSTIM1 fl/fl and cSTIM1 −/− mice following treatment with isoproterenol (ISO), a β-adrenergic agonist (Fig.  7A, Top) .
To gain additional insight into the enhanced cholinergic sensitivity, we recorded ECGs during the administration of the cholinergic receptor antagonist atropine (1 mg/kg) to anesthetized STIM1 fl/fl and cSTIM1 −/− mice. We observed a significant increase in the HR from 375 ± 16 bpm to 537 ± 26 bpm (n = 12, P < 0.005) in STIM1 fl/fl mice and from 310 ± 15 bpm to 510 ± 28 bpm (n = 9, P < 0.001) in cSTIM1 −/− mice. Application of β-adrenergic receptor antagonist propranolol (1 mg/kg) in the presence of atropine produced a comparable reduction in the HRs of STIM1 fl/fl and cSTIM1 −/− mice (Fig. S5) . Together, these data demonstrate that vagal tone was enhanced whereas sympathetic tone was unaltered in mice lacking cardiac STIM1 expression.
To determine if these changes in cholinergic sensitivity in cSTIM1 −/− mice were intrinsic to the SAN, we measured the effects of CCh on spontaneous pacemaking of SAN tissue in vitro, which lacks neural input, from STIM1 fl/fl and cSTIM1 −/− mice. The cSTIM1 −/− SAN tissue was more sensitive to CCh than the STIM1 fl/fl SAN, resulting in a leftward shift in doseresponse curves for AP firing rate (Fig. 7C) . To verify that this increase in cholinergic sensitivity resulted from loss of STIM1-dependent SOCE and not from abnormal development in the absence of STIM1, we analyzed the effects of CCh on STIM1 fl/fl SAN firing following acute inhibition of SOCE with BTP-2 (10 μM). Pharmacologic block of SOCE shifted the dose-response curve leftward, similar to the cSTIM1 −/− SAN (Fig. 7C) . Moreover, in the presence of BTP-2, the STIM1 fl/fl SAN firing rate was reduced by 10%, and became more sensitive to CCh compared with untreated controls (Fig. 7D) . When these studies are interpreted alongside recent work from others showing that Ca 2+ signaling in the SANCs is subject to cholinergic control (25), we suggest that STIM1-dependent SOCE is required to refill internal Ca 2+ stores and acts as a backup pacemaker to oppose the negative chronotropic effects of acetylcholine.
Computer Modeling of Action Potentials. To provide additional support for our experimental observations on the role of STIM1-dependent SOCE in SAN function, we used mathematical modeling to analyze the effects of I soc on APs of the SAN (Fig.  8A) . It should be noted that there is no available mathematical model for SAN APs that includes I soc , an inwardly rectifying current activated during rhythmic Ca 2+ release in the SAN. We therefore introduced our experimentally acquired data of I soc (conductance 0.05 nS/pF), as well as a background K + conductance (I bk ) and inwardly rectifying K + current (I K1 ) into a model based on the rabbit SAN ( Table 3 ). The introduction of I soc to this mathematical model resulted in an ∼10% increase in the SAN firing rate (Fig. 8A) . These findings are consistent with the decrease in SAN firing rate found with inhibition of I soc with BTP-2 or STIM1 deletion from the SAN (Fig. 7 C and D) . We also examined the output of this model by varying the Ca 2+ pump (SERCA2a) rate to mimic SR Ca 2+ store depletion. Changing I soc as a function of Ca 2+ pump activity influenced both the MDP of APs and the SAN firing rate (Fig. 8 B and C) , suggesting that I soc is involved in setting the MDP and the initiation of diastolic depolarization.
Discussion
For the first time, to our knowledge, we show a role for STIM1 and SOCE in the regulation of SAN pacemaking. Cardiac specific deletion of STIM1 or pharmacologic inhibition of Orai1 channels in mice caused a reduction in the SR Ca 2+ stores, which manifests as a relative bradycardia, enhanced cholinergic sensitivity, and pacemaker shifting. These studies therefore establish the importance of STIM1 as a regulator of Ca 2+ dynamics and electrophysiological function in SANCs and, thus, of cardiac pacemaking of the SAN. To provide mechanistic insight into the reduction in SR Ca 2+ store content in cSTIM1 −/− SANCs, we show that STIM1 is involved in the regulation of Ca 2+ entry pathways. Notably, we provide the first evidence, to our knowledge, that I CRAC is present in mouse SANCs. We also show that STIM1-dependent SOCE functionally interacts with NCX1 and that the augmented NCX1 activity in cSTIM1 −/− SANCs accelerates the HR to partially compensate for the relative bradycardia in these mice. Based on our modeling studies, we further propose that this SOCE-NCX1 interaction is likely to influence AP parameters, including diastolic depolarization rate and MDP. Taken together, our data support the notion that STIM1 is of fundamental importance to the Ca 2+ dynamics of SANCs. Here, STIM1 and SOCE are activated by the rhythmic release of Ca 2+ from the SR, which activates Orai1 to refill the SR stores. In this way, STIM1 ensures the fidelity of SAN Ca 2+ dynamics and the integrity of the cardiac pacemaker.
In the present work, we tested the hypothesis that STIM1 contributed to SAN automaticity by regulating Ca 2+ homeostasis in a manner similar to that seen in skeletal muscle (15) and lymphocytes (27) . Ca 2+ imaging studies have previously implicated SOCE in the SAN (28) . Although SOCE was attributed to transient receptor potential channels (TRPC) channels and even Orai1 channels, no membrane current measurements were made to validate this hypothesis. Here, we used whole-cell patch clamp recording of single SANCs to characterize I soc . Depletion of SR Ca 2+ stores in SANCs activated I soc that shared many features with the well-characterized Ca 2+ release-activated Ca 2+ current (CRAC) currents described in lymphocytes. I soc in SANCs exhibited inward rectification of the I-V, a positive reversal potential, and pharmacologic inhibition by BTP-2 and Gd 3+ (29, 30) . Given that I soc in SANCs is similar to I CRAC and that Orai1 is expressed in these cells, we conclude that I soc activated by STIM1 is mediated by Orai1 channels in SANCs.
Unlike in lymphocytes and other nonexcitable cells, SANCs have an extensive repertoire of ionic currents that orchestrate membrane excitability and the properties of the AP. As a result, we hypothesize that STIM1 and Orai1 interact with other membrane currents, as we propose for the interaction between I soc and I NCX1 . An interesting observation in the present studies is that loss of STIM1 in cSTIM1 -dependent decrease in L-type Ca 2+ currents, much as in CPVT mice (31, 32) . In lymphocytes and other nonexcitable cells, STIM1 is subject to oligomerization and migration in the ER in response to Ca 2+ store depletion, where STIM1 migrates from the perinuclear ER to the cortical ER beneath the plasma membrane (33) . STIM1 then interacts with and activates Orai1 channels resident in the plasma membrane. In the present study, we show that STIM1 is positioned in the SR membrane at the Z-line structures and near the sarcolemma, but that it does not undergo movement within the SR in response to store depletion. This localization suggests that, in SANCs, STIM1 is located in the subsarcolemmal SR membranes where it can rapidly activate Ca 2+ entry by Orai1 on a beat-to-beat basis. Meanwhile, the population of STIM1 located in the SR that attaches to the Z line may regulate SERCA activity on a beat-to-beat basis, as was described during skeletal muscle development (34) and recently was shown for cardiomyocytes by our group. In this way, STIM1 could target key elements of Ca 2+ signaling in SANCs including Orai channels, SERCA, and NCX1. These findings are likely to underlie the regulation of SAN pacemaking by STIM1-dependent Ca 2+ signaling. Although the mechanistic basis of this restricted mobility is not yet known, potential mechanisms may involve posttranslational modification of STIM1, temperature sensitivity, or binding of STIM1 to static structures such as intermediate filaments that are enriched excitable cells.
Based on our findings, we provide a potential mechanism by which STIM1 influences the rate of diastolic depolarization of SANCs. NCX1 is activated late in diastole by local Ca 2+ release and produces an inward current that contributes to diastolic depolarization (35, 36) . NCX1 is also activated during systole when Ca 2+ transients peak in response to emptying of SR Ca 2+ stores. Normally, with each AP, Ca 2+ transients decay as Ca 2+ recycles back to the SR stores via SERCA2a and is rapidly extruded across the plasma membrane via NCX1. In the current studies, we show that the steady-state NCX1 current was augmented in the cSTIM1 −/− SANCs despite no change in NCX1 protein levels. These data suggest that cytosolic Ca 2+ was preferentially extruded by NCX1 in cSTIM1 −/− SANCs, owing in part to chronic depletion of the SR Ca 2+ stores. In other words, a much larger portion of the Ca 2+ transient is extruded by NCX1 in cSTIM1 −/− SANCs than in STIM1 fl/fl SANCs. Because it is well established that depletion of SR Ca 2+ stores in SANCs slows the HR, the increase in I NCX1 in cSTIM1 −/− SANCs is likely to accelerate the SAN firing rate and thereby partially compensate for the loss of I soc . Thus, the compensatory increase in NCX1 activity may account for the relatively small change in the HR of cSTIM1 −/− mice.
Summary
In conclusion, our results demonstrate that STIM1 serves a fundamental role in SANCs, where it activates I soc , refills SR Ca 2+ stores, and regulates specific membrane currents (I Ca-L and I NCX1 ). STIM1 therefore influences cardiac pacemaking by linking the Ca 2+ and the membrane clocks. Deleting STIM1 from the SAN causes depletion of SR Ca 2+ store, slows the HR, increases responsiveness to cholinergic stimulation, and destabilizes primary pacemaker sites in the SAN. These findings are consistent with the SAN dysfunction that has been reported to occur in humans and mice with leaky Ca 2+ stores. These studies thus provide the initial evidence for the physiologic function of STIM1 in the SAN. Because of the specific expression of STIM1 in the SAN and sparing of atrial and ventricular cardiomyocytes, targeting SOCE might be a therapeutic strategy to treat SAN dysfunction and atrial arrhythmias.
Materials and Methods
Animals. STIM1-lacZ mice were genotyped as previously described (15) . STIM1 fl/fl mice (C57BL/6) were generated as previously described (37) . The α-MHC (Cardiac specific) Cre transgenic mice (α-MHC-Cre) (C57BL/6) were obtained from Jackson Laboratories. To generate cardiac-specific knockout of STIM1, αMHC-Cre transgenic mice were bred with founder STIM1 fl/fl mouse and the progeny STIM1 fl/-; α-MHC-Cre +/− were then back-crossed with ), hearts were isolated from appropriately aged mice and then fixed in 2% paraformaldehyde with 0.2% glutaraldehyde for 20 min at room temperature. Hearts were then washed in rinse solution (5 mM EGTA, 0.01% deoxycholate, 0.02% Nonidet P-40, 2 mM MgCl 2 ) and stained in LacZ staining solution (5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 5 mM EGTA, 0.01% deoxycholate, 0.02% Nonidet P-40, 2 mM MgCl 2 , 1 mg·mL -1 X-gal solution) overnight at room temperature.
Paraffin sections were cut using standard methods and counterstained with Eosin. For antibody staining and immunoblotting, hearts were isolated and stored at −80°C until sectioning or blotting. Polyclonal STIM-1 (Protein Tech group or sigma) and Orai1 (Alomone) antibodies were used at 1:250, and polyclonal HCN4 (Sigma) antibody was used at 1:500. After washing, staining with the secondary antibody, and counterstaining with DAPI, slides were mounted in Vectashield (Vector Laboratories). Electrophysiology. For ionic current recordings from single SANCs, the cells were plated in a Warner perfusion chamber. Patch pipette was pulled from borosilicate glass capillaries (Sutter, Inc.) with a Sutter P-87 micropipette puller. The pipette usually had a resistance of 4-6 MΩ when filled with pipette solution. The liquid junction potential was nulled before gigaseal formation. Whole-cell currents were recorded using an Axon AXOPatch 200B amplifier connected to a Digidata 1322A digital converter. Whole-cell currents were filtered at 2 KHz and sampled at a rate of 10 kHz. The data were collected through Clampex software 9.0 (Mol Device) and stored on a computer for further analysis. All experiments were carried out at room temperature, except those specified. -sensitive indicator, rhod-2 AM (Invitrogen; 5 μM in DMSO) for 20 min, and illuminated using a 520 ± 30 nm LED excitation light source (LEX2, Scimedia). The resulting Rhod-2 fluorescence signal (wavelength, ʎem = 580 ± 40 nm) was focused on a CMOS camera (Ultima, Scimedia; 100 × 100 pixels), and CaT movies during SAN activity were recorded with a high spatial (30 × 30 μm pixel size) and temporal (2-KHz frame rate) resolution. The CaT amplitude in each pixel was normalized between 0 and 1, and the activation time of CaT was defined as the moment of its maximum upstroke velocity [(dF/dt)max].
SAN Preparation and
ECG and Intracardiac Electrophysiology Studies. HRs from conscious mice were obtained from ECG data. Briefly, mice were first anesthetized with isoflurane, and ECG electrodes were then placed on the backs of the mice. After recovery from anesthesia, ECGs were recorded from conscious, ambulatory mice, and HRs were analyzed. Invasive mouse electrophysiology studies were performed as previously described (16) .
Computational Modeling. For modeling studies, previously described VoltageCa 2+ clock model of a pacemaker cell was modified by simply adding an inward SOCE current (I SOC ) (38) . Because we observed pacemaking shifting in the cSTIM1 −/− SAN, an inward rectifier K + current (I K1 ) and a background K + current (I bK ), which were also described in mouse SA node models, were also added in the model. Model equations, parameters, and variables for I SOC , I K1 , and I bK are shown below. Based on our experimental measurements, the maximal conductance (g SOC Þ and the time constant (τ SOC Þ of I SOC were set at 0.05 pA/pF and 1,000 ms, respectively. Data Analysis. Averaged results are presented as mean ± SEM. For in vivo studies, based on a power calculation using a 95% confidence interval and assuming a 20% difference in the magnitude of the effect between groups, a sample size of n (mice, SAN tissue, or cells) for each group was between 8 and 20 to achieve a statistical power of 80% (beta = 20%). Mice (WT vs. KO) were allocated randomly for ECG recording, in vivo electrophysiology, and tissue optical mapping. The direct interplay between maximal conductance of I soc (g soc , nS/pF) and cycle length (CL, ms) is shown at different rates of SERCA2a Ca 2+ uptake (Pup). SERCA2a pumping was set at 0.04, 0.012 and 0.006 mM/ms. (C ) AP changes at different SERCA pumping rates. MDP became more negative when g soc was removed at the reduced SERCA2a pump rates. Otherwise, no randomization was performed. The principal operator was blinded to the genotypes for in vivo procedures. Comparisons were made among sex-and age-matched controls for several independent litters. No data were excluded from analysis except those obtained from mice that died periprocedurally. A paired Student t test was used to compare measurements made in the same mice or in the same cells under two different conditions. An unpaired Student t test was used to compare two independent groups. All data points represent biologic replicates. For analysis of I-V curves, the currents at each membrane potential were averaged and plotted as mean ± SEM. At each membrane potential, means were tested for significance using an unpaired Student t test. A value of P < 0.05 was considered significant.
